Century Therapeutics, Inc. — Director's Dealing 2024

Aug 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2024-08-05

Reporting Person: Farid Adrienne (Chief Operations Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-05	Common Stock	S	1073	$1.827	Disposed	136163	Direct

Footnotes

F1: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.